Table 2

Thrombotic events in the four groups studied

ParameterAPS–RSA group (n=57)uRSA group (n=86)tRSA group (n=42)aPL group (n=30)p Value
Follow-up, years7.3±3.54–126.0±2.0 (4–10)6.2±1.3 (4–9)8.2±4.3(6–12)NS
Patients with thrombotic event11 (19.3)*†‡0 (0)*2 (4.8)†0 (0)‡<0.0001*‡
 Cerebral arterial infarction4000<0.05†
 Deep vein thrombosis2020
 Pulmonary embolism2000
 Ischaemic infarction2000
 Cerebellar arterial infarction1000
  • Values are mean±SD or n (%). Statistical comparisons are indicated by common superscripts.

  • aPL group, patients with positive tests for antiphospholipid antibodies (aPL) without pregnancy or thrombotic morbidity; APS–RSA group, antiphospholipid syndrome patients with recurrent spontaneous abortion; NS, not significant; tRSA group, patients with recurrent spontaneous abortion without aPL but with other known thrombophilias; uRSA group, patients with recurrent spontaneous abortion without aPL or other known thrombophilias.